Author

Alfredo J. Lucendo 1

1 Hospital General de Tomelloso,Tomelloso,Spain

A 12-WEEK TREATMENT WITH BUDESONIDE ORODISPERSIBLE TABLETS IN THE EOS-1 TRIAL FOR INCOMPLETE RESPONDERS SIGNIFICANTLY IMPROVES BOTH INFLAMMATORY AND FIBROSTENOTIC ENDOSCOPIC FEATURES IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS

Stephan Miehlke, Alfredo J. Lucendo, Christoph Schlag, Ulrike von Arnim, Javier Molina Infante, Christoph Schmöcker, Albert Jan Bredenoord, Constanza Ciriza De Los Ríos, Stefan Brückner, Ahmed Madisch, Stefan Schubert, Jamal Hayat, Stephen E. Attwood, Jan Tack, Ralph Mueller, Roland Greinwald, Alex Straumann, Alain M. Scho

A novel budesonide orodispersible tablet formulation is highly effective to maintain endoscopic inflammatory remission and even complete endoscopic remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

A novel budesonide orodispersible tablet with a special esophageal-targeting can induce complete clinical, endoscopic and histologic remission in active Eosinophilic Esophagitis: Results from a post-hoc analysis of the randomized, double-blind, placebo-controlled EOS-1 trial

Stephan Miehlke, Christoph Schlag, Alex Straumann, Michael Vieth, Ralph Mueller, Roland Greinwald, Alfredo J. Lucendo

A novel oral budesonide formulation is highly effective for induction of remission in patients with active eosinophilic esophagitis: Results from the 6-weeks open-label treatment phase of EOS-2 trial

Alfredo J. Lucendo, Christoph Schlag, Stephan Miehlke, Luc Biedermann, Cecilio Santander Vaquero, Dirk Hartmann, Jamal Hayat, Petr Hruz, Constanza Ciriza De Los Ríos, Arjan Bredenoord, Michael Vieth, Ralph Müller, Roland Greinwald, Alex Straumann

ALL AGES INCIDENCE AND PREVALENCE OF EOSINOPHILIC ESOPHAGITIS INCREASE CONTINIOUSLY IN CENTRAL SPAIN. A 12-YEAR POPULATION-BASED STUDY

Alfredo J. Lucendo

ALL AGES INCIDENCE AND PREVALENCE OF EOSINOPHILIC ESOPHAGITIS INCREASE CONTINIOUSLY IN CENTRAL SPAIN. A 12-YEAR POPULATION-BASED STUDY

Ángel Arias Arias, Alfredo J. Lucendo

BISMUTH QUADRUPLE REGIMEN WITH TETRACYCLINE OR DOXYCYCLINE VERSUS PYLERA<sup>®</sup> AS THIRD-LINE RESCUE THERAPY FOR H. PYLORI INFECTION: A PROSPECTIVE MULTICENTER ANALYSIS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Olga P Nyssen, Ángeles Pérez-Aísa, Luis Rodrigo-Sáez, Manuel Castro Fernandez, Manuel Pabón-Carrasco, Alma Keko-Huerga, Pilar Mata Romero, Juan Ortuño, Jesús Barrio, J Huguet, Ines Modollel, Noelia Alcaide, Alfredo J. Lucendo, Xavier Calvet, Monica Perona, Barbara Gomez, Blas Gomez Rodriguez, Pilar Varela, Manuel Jiménez-

BISMUTH QUADRUPLE THREE-IN-ONE SINGLE CAPSULE: 3 OR 4 TIMES DAILY? SUB-ANALYSIS OF THE SPANISH DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Ángeles Pérez-Aísa*, Olga P. Nyssen*, Alfredo J. Lucendo, Jesús Barrio, Blas Jose Gómez Rodríguez, Ignasi Puig, Marta Espada, Tomasso Di Maira, Juan Ortuño, Barbara Gomez, Monica Perona, Luis Fernández Salazar, Eduardo Iyo, Ana Campillo, Francis Mégraud, Manuel Jiménez Moreno, Alma Keco-Huerga, Leticia Moreira, Manuel Cas

BISMUTH QUADRUPLE THREE-IN-ONE SINGLE CAPSULE: 3 OR 4 TIMES DAILY? SUB-ANALYSIS OF THE SPANISH DATA OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Olga P Nyssen, Jose Gomez Rodriguez, Jesús Barrio, Manuel Castro Fernandez, Manuel Pabón-Carrasco, Alma Keko-Huerga, Marianela Mego, Ángeles Pérez-Aísa, Nuria Fernandez Moreno, Barbara Gomez, Llúcia Titó, Eduardo Iyo, José María Huguet, Alfredo J. Lucendo, Tommaso Di Maira, Francisco José Martinez Cerezo, Oscar Núñez Martín

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Ralph Mueller, Christoph Schlag, Christoph Schmöcker, Roland Greinwald, Luc Biedermann, Michael Vieth, Alfredo J. Lucendo, Cecilio Santander, Alex Straumann, Petr Hruz, Ahmed Madisch, Stephan Miehlke, Stephen E. Attwood, Arjan Bredenoord, Stefan Schubert, Constanza Ciriza De Los Ríos, Alain M. Schoepfer, Jamal Hayat, Ulri

Item 1 - 10 / 90
1
2 3 4 5 6 7 8 9